Shoulder to Shoulder Report issue

Foundation

Organization Overview

First Clinical Trial
2010
NCT01303016
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Shoulder to Shoulder